Protein Kinase C Activation by Helicobacter pylori in Human Gastric Epithelial Cells Limits Interleukin-8 Production Through Suppression of Extracellular Signal-Regulated Kinase
スポンサーリンク
概要
- 論文の詳細を見る
Helicobacter pylori (H. pylori) infection of gastric epithelial cells has been shown to induce interleukin (IL)-8 production, but the signal transduction mechanism leading to IL-8 production has not been clearly defined. Here, we investigate the role of protein kinase C (PKC) in the mechanism of induction of IL-8 release by H. pylori in human gastric epithelial cells. In MKN45 cells, H. pylori-induced IL-8 release was enhanced by treatment with PKC inhibitors (GF109203X and calphostin C) and PKC depletion, which completely inhibited PKC activity. Moreover, PKC inhibitors and PKC depletion increased extracellular signal-regulated kinase (ERK) activity and phosphorylation, but not calcium/calmodulin-dependent protein kinase II (CaMK II) activity, in response to H. pylori infection. PKC activated by H. pylori inhibited activation of ERK induced by H. pylori without affecting the CaMK II activity and negatively regulated IL-8 production in human gastric epithelial cells.
- 社団法人 日本薬理学会の論文
- 2004-03-01
著者
-
Kiniwa Mamoru
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Matsuura Naosuke
Pharmacology Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Nozawa Yoshihisa
Pharmacobioregulation Research Laboratory Hanno Research Center
-
Nozawa Yoshihisa
大鵬薬品工業薬理研究所
-
Nozawa Yoshihisa
Pharmacology Research Laboratory Tokushima Research Center Taiho Pharmaceutical Co. Ltd.
-
KANDA Atsuhiro
Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd.
-
NISHIHARA Katsushi
Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd.
-
AKIZAWA Yushiro
Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd.
-
ORIMOTO Naoki
Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd.
-
NAKANO Motoko
Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd.
-
UJI Tatsuya
Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd.
-
AJIOKA Hirofusa
Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd.
-
Matsuura Naosuke
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Uji Tatsuya
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Nakano Motoko
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Orimoto Naoki
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Kanda Atsuhiro
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Akizawa Yushiro
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Ajioka Hirofusa
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Nishihara Katsushi
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
関連論文
- Isolation and cDNA cloning of oxytocin/vasopressin superfamily peptides of Octopus vulgaris(Endocrinology)(Proceeding of the Seventy-Third Annual Meeting of the Zoological Society of Japan)
- Cell Type-Dependent Divergence of Transactivation by Glucocorticlid Receptor Ligand
- In Vivo Analysis of Glucocorticoid-Induced Reporter Gene Expression Using Gene Gun DNA Delivery
- IS005 Vascular Smooth Muscle Cell(VSMC)-Specific Overexpression of Angiotensin type2(AT2)Receptor Causes Endothelium-dependent Vasodilation via bradykinin/NO/cGMP pathway
- IS104 Cell-specific Distribution of Angiotensin II Receptor Subtypes and Receptors-mediated Biochemical Changes in Failing Human Hearts
- IS040 Angiotensin Type 2 (AT2) Receptor Inhibits AT1-mediated Intracelluar Alkalosis to Enhance Kinik Production in Vascular Smooth Muscle Cells From Vascular-targeted AT2 Transgenic Mice
- IS070 Angiotensin Type 2 Receptors Are Re-expressed by Cardiac Fibroblasts from Failing Myopathic Hamster Hearts and Inhibit Cell Growth and Fibrillar Collagen Metabolism
- IS050 Cardiac-Specific Overexpression of Angiotensin AT2 receptor Causes Attenuated Response to AT1 receptor - Mediated Chronotropic Action
- Enhancement of Ischemia-Induced Angiogenesis by eNOS Overexpression
- Augmented Angiogenesis in Ischemic Limbs in Transgenic Mice Overexpressing eNOS in Endothelium
- Systemic Delivery of Bone Marrow Mononuclear Cells(BM-MNC) Accelerates Reendothelialization and Markedly Attenuates Intimal Hyperplasia in Balloon-Injured Carotid Artery
- Effects of MET-88,a γ-Butyrobetaine Hydroxylase Inhibitor, on Tissue Carnitine and Lipid Levels in Rats
- QT PRODACT : Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles
- QT PRODACT : A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles
- Effects of Antimuscarinic Drugs on Both Urinary Frequency and Cognitive Impairment in Conscious, Nonrestrained Rats
- Protein Kinase C Activation by Helicobacter pylori in Human Gastric Epithelial Cells Limits Interleukin-8 Production Through Suppression of Extracellular Signal-Regulated Kinase
- TAS-301 Blocks Receptor-Operated Calcium Influx and Inhibits Rat Vascular Smooth Muscle Cell Proliferation Induced by Basic Fibroblast Growth Factor and Platelet-Derived Growth Factor